Home/R3 Vascular/Josh Smale
JS

Josh Smale

Vice President, Global Clinical and Scientific Affairs

R3 Vascular

R3 Vascular Pipeline

DrugIndicationPhase
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold SystemPeripheral Arterial Disease (PAD) - lesions in superficial femoral and proximal popliteal arteriesUnknown